Contact Congress about H.R. 6626: PFAS Accountability Act of 2025

People with major PFAS exposure could sue in federal court for regular health tests. A judge could make the responsible company pay if the legal tests are met. State lawsuit options would stay open.

Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.

PFAS Accountability Act of 2025 is a House bill in committee. The latest recorded action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Latest action on H.R. 6626: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Who this affects: This bill mainly affects people who were heavily exposed to PFAS and companies tied to making those chemicals. It could also affect communities near PFAS releases, doctors who provide monitoring, courts that hear the cases, and industries that use PFAS. The biggest change is who pays for long-term health testing when a court finds a company responsible.

Why this matters: People exposed to PFAS often face health worries before they have a diagnosed disease. This bill could let them seek testing earlier and shift the cost to companies found responsible. It could also push more research into PFAS health risks when current science is limited. The real impact would depend on how many cases people file and how judges apply the new rules.

Key provisions in H.R. 6626

• The bill adds a new PFAS exposure section to the Toxic Substances Control Act, a federal law that regulates many chemical risks.
• People and groups could sue for PFAS exposure in U.S. district court, which is the main federal trial court.
• A company could be sued if it helped make the PFAS at issue and knew, or should have known, people could be exposed.
• Judges could order medical monitoring, meaning regular health tests, if the person shows major exposure, higher PFAS-related disease risk, and a need for useful extra exams.
• The bill says courts should presume major exposure in some cases. That can happen if PFAS were released where a person could be exposed for at least one year, or if tests find PFAS in the person's body.

How Modern Action helps you take action on H.R. 6626

You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.

Questions people ask about H.R. 6626

What is H.R. 6626?

People with major PFAS exposure could sue in federal court for regular health tests. A judge could make the responsible company pay if the legal tests are met. State lawsuit options would stay open.

How do I support or oppose H.R. 6626?

Choose support, oppose, or ask for changes on Modern Action. The action flow drafts the message for you and keeps the wording tied to this bill.

Who should I contact about H.R. 6626?

Modern Action uses your location to route the action to the congressional offices relevant to the bill and your representation.

Can Modern Action explain H.R. 6626 before I act?

Yes. Modern Action gives you a plain-English summary, current status, and action context before you send anything.